Provided are compounds of formulae provided herein. The compounds may include pathway-preferential estrogens (PaPEs) derivatives with tissue-selective activities. Also provided are pharmaceutical compositions comprising the compounds, as well as methods of treating a disease or condition including administering the compounds. The disease or condition may include postmenopausal symptoms, cardiovascular disease, stroke, vascular disease, bone disease, metabolic disease, arthritis, osteoporosis, obesity, vasomotor/hot flush, cognitive decline, cancer including breast cancer.
Original languageEnglish (US)
U.S. patent number10703698
StatePublished - Jul 7 2020


Dive into the research topics of 'Compounds which activate estrogen receptors and compositions and methods of using the same'. Together they form a unique fingerprint.

Cite this